Diabetic neuropathy part 1: overview and symmetric phenotypes
- PMID: 23642717
- PMCID: PMC4090918
- DOI: 10.1016/j.ncl.2013.02.004
Diabetic neuropathy part 1: overview and symmetric phenotypes
Abstract
Diabetes is the most common cause of neuropathy in United States and neuropathies are the most common complication of diabetes mellitus, affecting up to 50% of patients with type 1 and type 2 diabetes mellitus. Symptoms usually include numbness, tingling, pain, and weakness. Dizziness with postural changes can be seen with autonomic neuropathy. Metabolic, vascular, and immune theories have been proposed for the pathogenesis of diabetic neuropathy. Axonal damage and segmental demyelination can be seen with diabetic neuropathies. Management of diabetic neuropathy should begin at the initial diagnosis of diabetes and mainly requires tight and stable glycemic control.
Copyright © 2013 Elsevier Inc. All rights reserved.
Figures
References
-
- Barohn RJ. Diabetic Neuropathy. Decision Making in Pain Management. (Second Edition) 2006:82–83.
-
- The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–1197. - PubMed
-
- Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the U.S. population ages 20–74. Diabetes. 1987;36:523–534. - PubMed
-
- Dyck PH, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester diabetic neuropathy study. Neurology. 1993;43:817–824. - PubMed
-
- Centers for Disease Control and Prevention. National Fact Sheet. Atlanta, GA: CDC, USHHS; 2011. [Accessed on December 1, 2012]. 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical